OmniSeq News

Dr. Carl Morrison featured in Future of Personal Health

Dr. Morrison, president of OmniSeq℠ Precision Medicine Technology, is featured as a “leading voice” in precision medicine. Buffalo, NY – June 29, 2015—The digital publication Future of Personal Health focuses on precision medicine in an article entitled...

read more

OmniSeq LLC: A Unique Approach to Personalized Medicine

By Alan Rosenhoch, Featuring Carl Morrison, MD, DVM Dr. Carl Morrison is founder, president and chief scientific officer of OmniSeq LLC – a recent Roswell Park Cancer Institute spinoff genomics firm. At Roswell Park, Dr. Morrison continues in his roles as Executive...

read more

Covaris, Inc. and OmniSeq, LLC Today Announced truXTRAC™ FFPE DNA Extraction and Purification Kit as the Method of Choice for Obtaining Clinical-Grade DNA from FFPE Samples for Use with OmniSeq Target℠ Testing

WOBURN, Mass., Sept. 1, 2015 /PRNewswire/ — truXTRAC is a comprehensive novel solution for clinical-grade DNA extraction from Formalin-Fixed, Paraffin-Embedded (FFPE) tissues utilizing Covaris Adaptive Focused Acoustics® (AFA™) technology. The unique focused,...

read more

Follow Us on Twitter

Cell proliferation is potentially a new biomarker of response to immune checkpoint inhibitors in NSCLC, and it is applicable to PD-L1 negative tumors. Many thanks to our academic collaborators for contributing their valuable samples and expertise!

Congratulations to OmniSeq's Antonios Papanicolau-Sengos et al. for publishing their promising research on the use of RNA-Seq to put forth novel immunotherapy targets in sarcoma #rna #immunotherapy

OmniSeq is proud to contribute to the real world evidence for the clinical utility of #NGS testing

Excited to publish in "The Prostate" with our collaborators from Roswell Park Comprehensive Cancer Center and University of California San Diego on how RNA-seq can be used to identify novel checkpoint inhibition targets #checkpoint #rna

Dr. Sean Glenn speaking in packed house at #SITC2018 on microsatellite instability by (NGS) Next Generation Sequencing.

Load More...